| Symbol | NTHI |
|---|---|
| Name | NEONC TECHNOLOGIES HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 23975 PARK SORRENTO,SUITE 205, CALABASAS, California, 91302, United States |
| Telephone | +1 818-570-6844 |
| Fax | — |
| — | |
| Website | https://neonc.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001979414 |
| Description | Our company (NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer. Additional info from NASDAQ: |
New Form D - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-25 <b>AccNo:</b> 0001829126-26-006874 <b>Size:</b> 14 KB
Read moreNeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum
Read moreNew Form EFFECT - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 9999999995-26-002092 <b>Size:</b> 1 KB
Read more(80% Positive) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Provides Update on status for adults
Read moreNew Form DEFA14A - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001829126-26-006776 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001829126-26-006775 <b>Size:</b> 1 MB
Read moreNew Form 424B5 - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001829126-26-006772 <b>Size:</b> 195 KB
Read moreNeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
Read moreBrain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND
Read moreNeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
Read more